Literature DB >> 11677282

Non-hepatic hyperammonaemia: an important, potentially reversible cause of encephalopathy.

N D Hawkes1, G A Thomas, A Jurewicz, O M Williams, C E Hillier, I N McQueen, G Shortland.   

Abstract

The clinical syndrome of encephalopathy is most often encountered in the context of decompensated liver disease and the diagnosis is usually clear cut. Non-hepatic causes of encephalopathy are rarer and tend to present to a wide range of medical specialties with variable and episodic symptoms. Delay can result in the development of potentially life threatening complications, such as seizures and coma. Early recognition is vital. A history of similar episodes or clinical risk factors and early assessment of blood ammonia levels help establish the diagnosis. In addition to adequate supportive care, investigation of the underlying cause of the hyperammonaemia is essential and its reversal, where possible, will often result in complete recovery. Detection of an unborn error of metabolism should lead to the initiation of appropriate maintenance therapy and genetic counselling.

Entities:  

Mesh:

Year:  2001        PMID: 11677282      PMCID: PMC1742166          DOI: 10.1136/pmj.77.913.717

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  29 in total

1.  A case of valproate-induced hyperammonemic encephalopathy: look beyond the liver.

Authors:  Saleh Alqahtani; Paolo Federico; Robert P Myers
Journal:  CMAJ       Date:  2007-09-11       Impact factor: 8.262

2.  Hyperammonemic encephalopathy in a patient with fibrolamellar hepatocellular carcinoma: case report and literature review.

Authors:  Janice Cho; Joy C Y Chen; Jonas Paludo; Erin E Conboy; Brendan C Lanpher; Steven R Alberts; Thorvardur R Halfdanarson
Journal:  J Gastrointest Oncol       Date:  2019-06

3.  Hyperammonaemia in V1a vasopressin receptor knockout mice caused by the promoted proteolysis and reduced intrahepatic blood volume.

Authors:  Masami Hiroyama; Toshinori Aoyagi; Yoko Fujiwara; Sayuri Oshikawa; Atsushi Sanbe; Fumio Endo; Akito Tanoue
Journal:  J Physiol       Date:  2007-03-22       Impact factor: 5.182

4.  Hyperammonaemic encephalopathy following an uncomplicated surgery.

Authors:  Stuart McIntosh; Karima Medjoub; Kevin Deans; Sara Sexton
Journal:  BMJ Case Rep       Date:  2017-08-16

5.  Noncirrhotic hyperammonemia causing relapsing altered mental status.

Authors:  Chibuzo Clement Odigwe; Binod Khatiwada; Christopher Holbrook; Ifeoma Sylvia Ekeh; Chukwuemeka Uzoka; Isaac Ikwu; Bishwas Upadhyay
Journal:  Proc (Bayl Univ Med Cent)       Date:  2015-10

6.  Analysis of cerebral blood flow and intracranial hypertension in critical patients with non-hepatic hyperammonemia.

Authors:  Alexandre Sanches Larangeira; Marcos Toshiyuki Tanita; Marcos Antonio Dias; Olavo Franco Ferreira Filho; Vinicius Daher Alvares Delfino; Lucienne Tibery Queiroz Cardoso; Cintia Magalhães Carvalho Grion
Journal:  Metab Brain Dis       Date:  2018-05-03       Impact factor: 3.584

7.  Hyperammonemic Encephalopathy Associated With Fibrolamellar Hepatocellular Carcinoma: Case Report, Literature Review, and Proposed Treatment Algorithm.

Authors:  Claudia I Chapuy; Inderneel Sahai; Rohit Sharma; Andrew X Zhu; Olga N Kozyreva
Journal:  Oncologist       Date:  2016-03-14

8.  Generalized convulsion resulted in hyperammonemia during treatment with tranexamic acid for hemoptysis.

Authors:  C-S Wang; C-J Yang; S-C Chen; H-C Chen; M-S Huang
Journal:  Ir J Med Sci       Date:  2009-11-17       Impact factor: 1.568

9.  Hemodialysis for hyperammonemia associated with ornithine transcarbamylase deficiency.

Authors:  Jacob F Collen; Nealanjon P Das; Jonathan M Koff; Robert T Neff; Kevin C Abbott
Journal:  Appl Clin Genet       Date:  2008-07-24

10.  Valproic Acid-induced hyperammonemia in the elderly: a review of the literature.

Authors:  Vikrant Mittal; Sunanda Muralee; Rajesh R Tampi
Journal:  Case Rep Med       Date:  2009-08-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.